ORIGINALMINE
LIVE

Serial Number

79318054

Owner

CG Bio Co., Ltd.

Attorney

Diane J. Mason

Filing Date

Jul 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ORIGINALMINE Trademark

Serial Number: 79318054 • Registration: 7008321

ORIGINALMINE is a trademark filed by CG Bio Co., Ltd. on July 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CG Bio Co., Ltd. (11 trademarks)

3F, 211, Itaewon-ro,

Entity Type: 03

Trademark Details

Filing Date

July 12, 2021

Registration Date

March 28, 2023

Published for Opposition

January 10, 2023

Goods & Services

Arterial grafts; implants comprising living tissue; surgical implants comprising living tissue; processed human donor skin for the replacement of soft tissue; live organs and tissues being surgical implants comprised of living tissue for surgical purpose; surgical implants comprised of living tissues; living tissue transplants in the nature of implants comprising living tissue; human allograft tissue; implants for guided tissue regeneration, namely, implants comprising living tissue; implantable materials for use in guided tissue regeneration in the nature of implants comprising living tissue; surgical implants comprised of living tissues, grown from stem cells; skin grafts; living tissue vascular grafts; syringes sold filled with hyaluronic acid for medical purposes; pre-filled syringes of hyaluronic acid for medical purposes; medicinal infusions for treating soft tissue infections of the skin; medicinal infusions, namely, medicated skin care preparations for treating the lips and face; medicinal infusions for breast augmentation and penis enlargement; medicinal infusions for implanting artificial bones; medicinal infusions with demineralized bone matrix (DBM), biocompatible ceramic material and poloxamers derived from human tissue, for accelerating bone formation; pharmaceutical preparations for the treatment of wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for treating damaged skin and tissue; medicines for human purposes, namely, medicated skin care preparations for treating foot ulcers, dry and itchy skin, postoperative wounds and burned skin; injectable dermal fillers; implantable medicines being surgical implants comprised of living tissues

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 4, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 13, 2023 FICS
FINAL DISPOSITION PROCESSED
Jul 13, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 28, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 6, 2023 OPNX
NOTIFICATION PROCESSED BY IB
Jan 24, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 18, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 18, 2023 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 23, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 11, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 11, 2022 GNFR
FINAL REFUSAL WRITTEN
Aug 11, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2022 TROA
REFUSAL PROCESSED BY IB
May 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 18, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 18, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 13, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 12, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 21, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 12, 2021 REPR